Literature DB >> 2594397

The prevalence and impact of pain after day-care tubal ligation surgery.

R A Fraser1, S B Hotz, J B Hurtig, S N Hodges, D Moher.   

Abstract

Empirical data from controlled studies using standardized, reliable measures on the amount and quality of pain after laparoscopic tubal ligation and the consequences of this pain on the activities of daily living are extremely scarce. In a study of 54 women admitted to a day-care unit for this procedure, validated measures were utilized to assess the incidence, intensity and duration of pain after tubal ligation (McGill Pain Questionnaire) and the impact of pain on the activities of daily living (Modified Functional Assessment Inventory). Psychological measures (Brief Symptom Inventory, Kranz Health Opinion Survey, and the State-Trait Anxiety Inventory) were employed to test their use as possible predictors for pain, analgesic usage and the time taken to resume a normal activity level after tubal ligation surgery. The results showed that pain is a significant problem after tubal ligation although pain rating scores over the 7-day study period were lower than those reported after major abdominal surgery. Eighty-five percent of our sample reported that pain and/or fatigue impacted on their recovery and contributed to an average delay of return to normal activity level of 4.4 days, not including the day of surgery. The psychological measures did not prove to be strong predictors of postoperative pain, time of return to normal activity level or analgesic usage. The most powerful predictor of return to normal activity was the total amount of pain experienced, as measured by the McGill Pain Questionnaire, during the 7 day post-operative period.

Entities:  

Keywords:  Americas; Analgesia--administraction and dosage; Behavior; Canada; Data Analysis; Developed Countries; Diseases; Family Planning; Female Sterilization; Gynecologic Surgery; Measurement; North America; Northern America; Pain; Prevalence; Psychological Factors; Questionnaire Design; Research Methodology; Sampling Studies; Signs And Symptoms; Sterilization, Sexual; Studies; Surgery; Survey Methodology; Surveys; Treatment; Tubal Ligation; Tubal Occlusion; Urogenital Surgery

Mesh:

Year:  1989        PMID: 2594397     DOI: 10.1016/0304-3959(89)90006-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

1.  Hysteroscopic sterilization: history and current methods.

Authors:  James A Greenberg
Journal:  Rev Obstet Gynecol       Date:  2008

Review 2.  Regional anesthesia for laparoscopic surgery: a narrative review.

Authors:  George Vretzakis; Metaxia Bareka; Diamanto Aretha; Menelaos Karanikolas
Journal:  J Anesth       Date:  2013-11-07       Impact factor: 2.078

3.  Major laparoscopic surgery under regional anesthesia: A prospective feasibility study.

Authors:  R K Singh; A M Saini; Nitin Goel; Dinesh Bisht; Atul Seth
Journal:  Med J Armed Forces India       Date:  2015-02-11

4.  Serum concentrations of local anaesthetics following intraperitoneal administration during laparoscopy.

Authors:  P Narchi; D Benhamou; H Bouaziz; H Fernandez; J X Mazoit
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Failure of meperidine wound infiltration to reduce pain after laparoscopic tubal ligation.

Authors:  L Forgach; B Y Ong
Journal:  Can J Anaesth       Date:  1995-12       Impact factor: 5.063

6.  Post-herniorrhaphy pain in outpatients after pre-incision ilioinguinal-hypogastric nerve block during monitored anaesthesia care.

Authors:  Y Ding; P F White
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

7.  Pain associated with hysteroscopic sterilization.

Authors:  Radha Syed; Jenna Levy; Meredith E Childers
Journal:  JSLS       Date:  2007 Jan-Mar       Impact factor: 2.172

8.  Perioperative Dexmedetomidine for outpatient cataract surgery: a systematic review.

Authors:  James Harvey Jones; Robin Aldwinckle
Journal:  BMC Anesthesiol       Date:  2020-04-04       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.